1 / 8

Global Acute Myeloid Leukemia Therapeutics market to grow at a CAGR of 19.75 percent over the period 2014-2019

Big Market Research has announced a new Report Package "Global Acute Myeloid Leukemia Therapeutics Market -Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential"<br><br>Get Complete Details At: http://www.bigmarketresearch.com/global-acute-myeloid-leukemia-therapeutics-2015-2019-market<br><br>Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor cells. Neoplasms arise from bone marrow, however, it spreads quickly into the blood. In the later stages of the disorder, it spreads to spleen, lymph node, liver, brain, spinal cord and testicles. Clonal expansion of the myeloid blasts and the loss of normal hematopoiesis are the main characteristic of acute myeloid leukemia.<br><br>Enquire At: http://www.bigmarketresearch.com/report-enquiry/169995<br>

zac_cocks
Download Presentation

Global Acute Myeloid Leukemia Therapeutics market to grow at a CAGR of 19.75 percent over the period 2014-2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Acute Myeloid Leukemia Therapeutics Market 2015-2019 Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2019 Published Date: Dec2014

  2. Report Description About Acute Myeloid Leukemia Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor cells. Neoplasms arise from bone marrow, however, it spreads quickly into the blood. In the later stages of the disorder, it spreads to spleen, lymph node, liver, brain, spinal cord and testicles. Clonal expansion of the myeloid blasts and the loss of normal hematopoiesis are the main characteristic of acute myeloid leukemia. The disease affects the elderly people with age of 67 years. Fever, pallor, fatigue and hemorrhages are some of the clinical symptoms of the disease. Smoking, exposure to certain chemicals such as benzene, exposure to radiations, cancer patients, who are treated with chemotherapy, blood disorder or genetic mutations are some of the risk factors for the development of acute myeloid leukemia in patients. Get Complete Report At: http://www.bigmarketresearch.com/global-acute-myeloid-leukemia-therapeutics-2015-2019-market The Global Acute Myeloid Leukemia Therapeutics market to grow at a CAGR of 19.75 percent over the period 2014-2019.

  3. Report Description Covered in this Report This report covers the present scenario and the growth prospects of the Global Acute Myeloid Leukemia Therapeutics market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic, off-label and branded therapies used for treatment. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Acute Myeloid Leukemia Therapeutics market. In addition, the report discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Enquire About This Report At: http://www.bigmarketresearch.com/report-enquiry/169995 Global Acute Myeloid Leukemia Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC regions and the EMEA regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

  4. Report Description Key Regions • Americas • APAC • EMEA Key Vendors • Bristol Myers Squibb • Celgene • Johnson & Johnson • Pfizer Other Prominent Vendors • Abbott • Ambit BioSciences • Amgen • Astex Pharmaceuticals • AstraZeneca • Baxter Healthcare • Bayer

  5. Report Description • BoehringerIngelheim • Celator Pharmaceuticals • Chroma Therapeutics • Chugai Pharmaceutical • CTI Biopharma • Cyclacel Pharmaceuticals • Eisai • F. Hoffmann-La Roche • Immune Pharmaceuticals • Innate Pharma • Kanisa Pharmaceuticals • Meda • Merck Sharp & Dohme • Midas Pharmaceuticals • Neovii Biotech • Nippon Shinyaku • Novo Nordisk • Sanofi • Sunesis Pharmaceuticals • Teva Pharmaceutical • Tolero Pharmaceuticals

  6. Report Description Market Driver • Unmet Needs in the Market • For a full, detailed list, view our report Market Challenge • Expensive Treatment • For a full, detailed list, view our report Market Trend • Expected Entry of Novel Therapies • For a full, detailed list, view our report Key Questions Answered in this Report • What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?

  7. Table Of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Product Profiles 05. Market Research Methodology 06. Introduction 07. Disease Overview 08. Market Landscape 09. Market Segmentation by Class of Drugs 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Pipeline Portfolio Get Complete TOC At: http://www.bigmarketresearch.com/global-acute-myeloid-leukemia-therapeutics-2015-2019-market

  8. FOR MORE DETAILS Visit us at : http://www.bigmarketresearch.com/global-acute-myeloid-leukemia-therapeutics-2015-2019-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: help@bigmarketresearch.com

More Related